Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human RBBP6 Antibodies:
anti-Mouse (Murine) RBBP6 Antibodies:
anti-Rat (Rattus) RBBP6 Antibodies:
Go to our pre-filtered search.
Human Polyclonal RBBP6 Primary Antibody for ICC, IF - ABIN4349510
Kishikawa, Otsuka, Yoshikawa, Ohno, Ijichi, Koike: Satellite RNAs promote pancreatic oncogenic processes via the dysfunction of YBX1. in Nature communications 2016
Show all 2 Pubmed References
RBBP6 might potentiate cervical carcinoma cell viability.
Results from a study on gene expression variability markers in early-stage human embryos shows that RBBP6 is a putative expression variability marker for the 3-day, 8-cell embryo stage.
RBBP6 overexpression could resist colorectal cancer cells against radiation.
These results suggest that the RBBP6-3 isoform may be involved in promoting apoptosis in cancerous cells.
RBBP6 is a candidate gene for myeloproliferative neoplasms (MPNs) susceptibility in a subset of pedigrees with familial MPN (show PRSS27 Antibodies).
High expression levels of RBBP6 and high apoptosis levels were found in HIV-associated nephropathy (HIVAN) cases. This direct association between RBBP6 expression and apoptosis levels suggests that RBBP6 play a role in HIVAN pathogenesis.
RBBP6 prevents DNA damage by destabilizing the transcriptional repressor ZBTB38 (show ZBTB38 Antibodies).
RBBP6 gene variants are associated with glioma and contribute to glioma susceptibility
implicate RBBP6 and iso3 as novel regulators of 3' processing, especially of RNAs with AU-rich 3' UTRs.
these findings suggest that RBBP6 isoform 3 is a cell cycle regulator and may be deregulated in carcinogenesis
P2P-R expression may be translationally regulated by PUM2 (show PUM2 Antibodies) and that P2P-R may modulate translation by influencing ribosomal protein gene expression
the PACT-p53 (show TP53 Antibodies) interaction plays a critical role in embryonic development and tumorigenesis and identify PACT as a member of negative regulators of p53 (show TP53 Antibodies).
Mapped six genes (EIF4G3 (show EIF4G3 Antibodies), HSP90 (show HSP90AB1 Antibodies), RBBP6, IL8 (show IL8 Antibodies), TERT (show TERT Antibodies), and TERC) on the chromosomes of Equus caballus, Equus asinus, Equus grevyi, and Equus burchelli by fluorescence in situ hybridization.
The retinoblastoma tumor suppressor (pRB) protein binds with many other proteins. In various human cancers, pRB suppresses cellular proliferation and is inactivated. Cell cycle-dependent phosphorylation regulates the activity of pRB. This gene encodes a protein which binds to underphosphorylated but not phosphorylated pRB. Multiple alternatively spliced transcript variants that encode different isoforms have been found for this gene.
E3 ubiquitin-protein ligase RBBP6
, RB-binding Q-protein 1
, p53-associated cellular protein of testis
, proliferation potential-related protein
, protein P2P-R
, retinoblastoma-binding Q protein 1
, retinoblastoma-binding protein 6
, retinoblastoma binding protein 6
, retinoblastoma-binding protein 6-like